Bleichroeder’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$531K Hold
288,679
– – 0.05% 80
2026
Q2
$803K Buy
288,679
+188,679
+189% +$528K 0.14% 48
2026
Q1
$254K Hold
100,000
– – 0.04% 56
2025
Q4
$295K Hold
100,000
– – 0.05% 52
2025
Q3
$560K Buy
+100,000
New +$495K 0.11% 45

Other funds holding CLRB

Bleichroeder's CLRB Position: Q3 2026 in Review

Bleichroeder held its Cellectar Biosciences (CLRB) position steady in Q3 2026 at 288,679 shares worth $531K. The position accounts for 0.05% of the portfolio, ranked #80.

Bleichroeder first reported a position in CLRB in Q3 2025 and has held it in 5 quarters since. The position peaked at $803K in Q2 2026. 20 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.

  • Bleichroeder held 288,679 shares of Cellectar Biosciences worth $531K as of Q3 2026.
  • Bleichroeder left its Cellectar Biosciences share count unchanged in Q3 2026.
  • Cellectar Biosciences made up 0.05% of Bleichroeder's portfolio in Q3 2026, its #80 holding.
  • Bleichroeder first reported a position in Cellectar Biosciences in Q3 2025 and has held it in 5 quarters since.
  • Bleichroeder's Cellectar Biosciences position peaked at $803K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.